What it's for (Indications)
- Norethisterone, a synthetic progestogen, is prescribed for a range of gynecological conditions primarily due to its ability to stabilize the endometrium and inhibit gonadotropin secretion.
- Key indications include the treatment of dysfunctional uterine bleeding (menorrhagia and metrorrhagia) by establishing a secretory endometrium and promoting a controlled withdrawal bleed.
- It is also effectively used in the management of endometriosis, where it helps to suppress endometrial tissue growth outside the uterus.
- Other established uses encompass the treatment of premenstrual syndrome (PMS) by modulating hormonal fluctuations, and the postponement of menstruation for specific circumstances.
- Furthermore, norethisterone is integral in hormone replacement therapy (HRT) regimens for postmenopausal women who have an intact uterus, where it is administered to counteract estrogen-induced endometrial proliferation and reduce the risk of endometrial hyperplasia and carcinoma.
- It can also be indicated for primary or secondary amenorrhea, often following estrogen priming.
- This medication is not indicated for contraception when used alone for these therapeutic purposes.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of norethisterone is highly individualized and depends critically on the specific indication, patient response, and overall clinical picture. For dysfunctional uterine bleeding, a common regimen involves 5-10 mg daily for 10 days, typically followed by a withdrawal bleed a few days after cessation. In the management of endometriosis, treatment often commences with 5 mg daily, gradually increasing to 10-15 mg daily over a period of several months, requiring continuous administration. For the postponement of menstruation, a dose of 5 mg three times daily is usually initiated approximately 3 days before the expected onset of the menstrual period, and continued for no longer than 10-14 days. For premenstrual syndrome, a typical dosage might be 5 mg once or twice daily during the luteal phase of the cycle, such as from day 19 to day 26. In hormone replacement therapy, it can be administered continuously at 1-5 mg daily or cyclically, depending on the chosen regimen. All dosage adjustments and treatment durations must be determined by a qualified healthcare professional, considering potential risks and benefits. It is crucial for patients to adhere strictly to the prescribed dosage and not self-adjust without medical guidance. |
Safety & Warnings
Common Side Effects
- Norethisterone, like all medications, can cause a range of side effects, some of which are more common and generally mild, while others can be serious.
- Common adverse effects often observed include nausea, headache, breast tenderness or pain, abdominal cramps, and irregular vaginal bleeding or spotting, particularly during the initial cycles of treatment.
- Mood changes, such as depression, irritability, and anxiety, as well as changes in libido and weight fluctuation (gain or loss) are also frequently reported.
- Less common but potentially more serious side effects include an increased risk of thromboembolic events such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (heart attack), and stroke, especially in individuals with pre-existing risk factors.
- Hepatic dysfunction, manifesting as jaundice or elevated liver enzymes, can occur.
- Other significant but less frequent effects include hypertension, fluid retention (leading to edema), visual disturbances, exacerbation of migraine, and allergic skin reactions (rash, pruritus).
- Patients should be advised to report any persistent or severe side effects to their healthcare provider immediately.
Serious Warnings
- Black Box Warning: ### Serious Warnings Regarding Thromboembolic Risk and Other Significant Adverse Events While norethisterone, when used alone for gynecological indications, does not typically carry a formal FDA-style 'Black Box Warning' equivalent to those associated with combined oral contraceptives or estrogen-containing hormone replacement therapies, healthcare professionals and patients must be fully aware of the significant and potentially life-threatening risks associated with its use. As a progestogen, norethisterone is associated with an increased risk of **venous and arterial thromboembolic events**, including deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. This risk is amplified in individuals with pre-existing risk factors such as advanced age, smoking, obesity, prolonged immobilization, major surgery, severe hypertension, hyperlipidemia, and diabetes mellitus. Patients experiencing sudden severe headache, visual disturbances, chest pain, shortness of breath, or unexplained limb pain/swelling must seek immediate medical attention, as these could be signs of a thrombotic event. Additionally, serious **hepatic dysfunction** and the development of **liver tumors** (both benign and malignant) have been reported with progestogen use, necessitating careful monitoring in patients with a history of liver disease or those who develop jaundice. Norethisterone may also affect **glucose metabolism**, requiring vigilant monitoring in diabetic patients. The potential for **exacerbation of depression** and significant **cardiovascular risks** underscores the critical need for a comprehensive assessment of patient history and ongoing monitoring throughout treatment. Prescribers should weigh these serious risks against the potential benefits for each individual patient.
- Patients receiving norethisterone require careful monitoring, especially those with pre-existing medical conditions.
- A primary concern is the increased risk of thromboembolic events; therefore, patients with a history of venous or arterial thromboembolism, or significant risk factors such as severe obesity, prolonged immobility, major surgery, or heavy smoking, should be evaluated thoroughly.
- Caution is advised in patients with a history of depression, as progestogens can exacerbate mood disturbances.
- Patients with impaired liver function or a history of jaundice during pregnancy or prior steroid use should be closely observed due to the drug's hepatic metabolism.
- Norethisterone may affect glucose tolerance; diabetic patients should be monitored closely.
- Conditions that may be exacerbated by fluid retention, such as asthma, epilepsy, migraine, or cardiac/renal dysfunction, necessitate cautious use.
- Discontinue norethisterone immediately if any signs of a thrombotic event (e.
- g.
- , sudden severe headache, visual disturbances, chest pain, leg swelling), severe liver dysfunction, or significant blood pressure elevation occur.
- Regular medical evaluations, including blood pressure measurements and liver function tests, are recommended during prolonged therapy.
- The potential for interaction with other medications, particularly enzyme-inducing drugs, must also be considered.
How it Works (Mechanism of Action)
Norethisterone is a synthetic progestogen, structurally related to testosterone, that exerts its primary pharmacological effects by mimicking the actions of endogenous progesterone. Its main mechanism involves binding to progesterone receptors in target tissues, most notably the uterus, hypothalamus, and pituitary gland. In the uterus, norethisterone induces a complete secretory transformation of the estrogen-primed proliferative endometrium, which is crucial for treating dysfunctional uterine bleeding and preventing endometrial hyperplasia when used in conjunction with estrogen in HRT. When administered at higher doses, particularly in contexts like contraception or endometriosis management, it suppresses the hypothalamic-pituitary-ovarian axis, leading to inhibition of gonadotropin release (luteinizing hormone and follicle-stimulating hormone). This suppression prevents ovulation. Furthermore, norethisterone increases the viscosity of cervical mucus, making it less penetrable to sperm, and alters the motility of the fallopian tubes, further contributing to its effect in some indications. Its partial androgenic activity is generally negligible at typical therapeutic doses but contributes to its steroid hormone profile.
Commercial Brands (Alternatives)
No other brands found for this formula.